Edition:
India

Biotest AG (BIOG_p.DE)

BIOG_p.DE on Xetra

20.00EUR
9:08pm IST
Change (% chg)

€-0.00 (-0.02%)
Prev Close
€20.00
Open
€19.81
Day's High
€20.19
Day's Low
€19.81
Volume
12,922
Avg. Vol
29,048
52-wk High
€23.88
52-wk Low
€12.96

Select another date:

Tue, Nov 14 2017

BRIEF-Biotest 9-mth revenue at EUR 377.8 mln

* DGAP-NEWS: BIOTEST AG: BIOTEST GENERATES REVENUES OF EUR 377.8 MILLION IN THE FIRST NINE MONTHS 2017

Takeover of plasma firm Biotest by China's Creat hits wall in U.S

FRANKFURT Chinese investor Creat Group Corp has withdrawn and will rework its application for U.S. approval of a planned takeover of Biotest amid concerns over national security, the German blood plasma products maker said, sending its shares sharply lower.

China's Creat suffers setback in Biotest deal on U.S. scrutiny

FRANKFURT Chinese investor Creat Group Corp has withdrawn its application for U.S. approval of a planned 1.3-billion-euro ($1.51-billion) takeover of Biotest , the German blood plasma products maker said, sending its shares sharply lower.

BRIEF-Biotest: Tiancheng withdrawal of application of transaction from CFIUS and refiling

* ‍TENDER OFFER BY TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG​

BRIEF-Curetis partners with Biotest to support academic PEPPER Pentaglobin Peritonitis trial

* CURETIS PARTNERS WITH BIOTEST TO SUPPORT ACADEMIC PEPPER PENTAGLOBIN® PERITONITIS TRIAL WITH UNYVERO IAI APPLICATION

BRIEF-Biotest H1 result swings to loss of 17.8 million euros

* H1 REVENUE FROM CONTINUING OPERATIONS FELL 11 PERCENT TO 247.1 MILLION EUR

BRIEF-Biotest takes over plasma supplier Cara Plasma s.r.o.

* ‍BIOTEST TAKES OVER CARA PLASMA S.R.O. WITH ONE PLASMA COLLECTION CENTRE IN CZECH REPUBLIC​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Tiancheng Pharmaceutical Holdings: offer for Biotest accepted for 89.9 pct of share capital‍​‍​

* TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG - AFTER END OF ADDITIONAL ACCEPTANCE PERIOD OFFER ACCEPTED FOR 17.8 MILLION BIOTEST SHARES, THAT IS 89.9% SHARE CAPITAL‍​‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Biotest reaches 2nd milestone in expansion project

* DGAP-NEWS: BIOTEST AG: BIOTEST REACHES 2ND MILESTONE IN BIOTEST NEXT LEVEL EXPANSION PROJECT

BRIEF-Tiancheng Pharmaceutical Holdings: additional acceptance period for Biotest tender offer

* START OF MANDATORY ADDITIONAL ACCEPTANCE PERIOD FOR BIOTEST AG TENDER OFFER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: